If there is widespread adoption of 18F-labeled, PSMA-targeted radiotracers for PCa imaging or even an incorporation of those agents in clinical guidelines, such observations are of utmost importance for establishing adequate imaging protocols. The gene discussed is FOLH1; the disease is posterior cortical atrophy.